TRILIPIX has now been studied in combination with the most commonly used doses of CRESTOR (5 mg, 10 mg, 20 mg) in patients with mixed dyslipidemia Orlando — Data from a new study showed that Abbott’s ...

Newswise — New data presented today at the American Heart Association's Annual Scientific Sessions showed that AstraZeneca's CRESTOR® (rosuvastatin calcium) at 10 and 20 mg reduced LDL-C or "bad" ...

Newswise — AstraZeneca (NYSE:AZN) announced today that its new cholesterol-lowering medication, CRESTOR® (rosuvastatin calcium) has received approval from the U.S. Food and Drug Administration (FDA) ...

March 2, 2005 -- The U.S. Food and Drug Administration (FDA) has advised healthcare professionals and consumers via public health advisory and information sheets of recommendations for the safe use of ...

The recommended dosage range for rosuvastatin is 5 to 40 mg per day. The prescribed dosage may depend on your individual treatment plan. Other factors, including your specific diagnosis, age, and ...

MUMBAI, India The Food and Drug Administration has given tentative approval to a generic cholesterol drug made by Sun Pharmaceutical Industries. Sun announced Wednesday the tentative approval of ...

June 8, 2005 — The U.S. Food and Drug Administration (FDA) approved in March revisions to safety labeling to advise that use of rosuvastatin calcium tablets is associated with an increased risk of ...

Rosuvastatin is also prescribed to treat high cholesterol caused by genetics in certain children. It is available as the brand-name drug Crestor. An interaction occurs when one substance causes ...

WILMINGTON, Del. The U.S. District Court for the District of Delaware has upheld the patent on a cardiovascular drug made by AstraZeneca, the Anglo-Swedish drug maker said Tuesday. Judge Joseph Farnan ...